Michael B. Fowler, MB, FRCP
Cardiologist
Professor of Medicine (Cardiovascular) at the Stanford University Medical Center
Dr. Michael Fowler is a Professor of Cardiovascular Medicine at Stanford Hospital & Clinics.
Dr. Fowler attended the Charing Cross Hospital Medical School, London, England. He has been elected to be a fellow in the Royal College of Physicians. He came to Stanford University on a British Heart Foundation, American Heart Association reciprocal fellowship award.
Dr. Fowler was appointed to the faculty in 1982. He is the Medical Director of the Heart Failure Program at Stanford University School of Medicine and Medical Director of the Stanford Cardiomyopathy Center.
Dr. Fowler has specialized in the treatment and research related to heart failure for over 30 years. He played an important role in the development of beta blocking drugs to treat heart failure and has also participated in most and the major studies that have led to our current comprehensive treatment for heart failure with drugs and devices. He is an expert in evaluating patients who may benefit from cardiac transplantation or mechanical support therapy.
PRACTICE AREAS
PROFESSIONAL EDUCATION
- Fellowship: Stanford University School of Medicine (1984) CA
- Research Fellowship, Stanford University School of Medicine (1984)
- Fellowship, Kings College Hospital UK (1982)
ADMINISTRATIVE APPOINTMENTS
- Assistant Professor of Medicine, CardiovascularMedicine, Stanford University Medical Center (1986 - 1993)
- Assoc. Prof. of Medicine, CardiovascularMedicine, Stanford University Medical Center (1993 - 1999)
- Clinical Asst. Prof. of Medicine, Stanford University Medical Center (1984 - 1986)
PUBLICATIONS
- Selecting candidates for cardiac transplantation. How to assess exclusion criteria and predict who will benefit.
Rickenbacher, P. R., Haywood, G., & Fowler, M. B. (1995). Selecting candidates for cardiac transplantation. How to assess exclusion criteria and predict who will benefit. The Journal of Critical Illness, 10(3), 199–206. - The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure
Fowler, M. B. (1999). The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure. JOURNAL OF CARDIOVASCULAR RISK, 6(3), 141–44. - Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
Myers, J., Gullestad, L., Vagelos, R., Do, D., Bellin, D., Ross, H., & Fowler, M. B. (2000). Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. AMERICAN HEART JOURNAL, 139(1), 78–84.
- 300 Pasteur Drive
- 2nd Floor, Room A260
- Stanford , CA 94305
- Phone: 650-724-4942
Source: https://stanfordhealthcare.org/doctors/f/michael-fowler.html
Comments